A Novel Activator of C-C Chemokine, FROUNT, is Expressed With C-C Chemokine Receptor 2 and its Ligand in Failing Human Heart

Journal of Cardiac Failure

Volumn 13, Issue 2, 2007, Pages 114-119

  Satoh, Mamoru ^a   Akatsu, Tomonari ^a   Ishkawa, Yuh ^a   Minami, Yoshitaka ^a   Nakamura, Motoyuki ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Congestive heart failure; Dilated cardiomyopathy; In situ hybridization; Real time RT PCR

Indexed keywords

BETA CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR2; FROUNT PROTEIN; LIGAND; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CYTOPLASM; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

BIOLOGICAL MARKERS; CHEMOKINE CCL2; CLATHRIN HEAVY CHAINS; DISEASE PROGRESSION; DNA PROBES; ENDOCARDIUM; FEMALE; GENE EXPRESSION; HEART FAILURE, CONGESTIVE; HUMANS; IN SITU HYBRIDIZATION; LIGANDS; MALE; MIDDLE AGED; RECEPTORS, CHEMOKINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX;

EID: 33947511583     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2006.11.003     Document Type: Article

References (19)

1. Satoh M., Nakamura M., Saitoh H., Satoh H., Maesawa C., Segawa I., et al. Tumor necrosis factor-α-converting enzyme and tumor necrosis factor-α in human dilated cardiomyopathy. Circulation 99 (1999) 3260-3265
2. Satoh M., Nakamura M., Satoh H., Saitoh H., Segawa I., and Hiramori K. Inducible nitric oxide synthase and tumor necrosis factor-alpha in myocardium in human dilated cardiomyopathy. J Am Coll Cardiol 29 (1997) 716-724
3. Satoh M., Nakamura M., Akatsu T., Shimoda Y., Segawa I., and Hiramori K. Myocardial osteopontin expression is associated with collagen fibrillogenesis in human dilated cardiomyopathy. Eur J Heart Fail 7 (2005) 755-762
4. Satoh M., Iwasaka J., Nakamura M., Akatsu T., Shimoda Y., and Hiramori K. Increased expression of tumor necrosis factor-α converting enzyme and tumor necrosis factor-alpha in peripheral blood mononuclear cells in patients with advanced congestive heart failure. Eur J Heart Fail 6 (2004) 869-875
5. Devaux B., Scholz D., Hirche A., Klovekorn W.P., and Schaper J. Upregulation of cell adhesion molecules and the presence of low grade inflammation in human chronic heart failure. Eur Heart J 18 (1997) 470-479
6. Taub D.D., and Oppenheim J.J. Chemokines, inflammation and the immune system. Ther Immunol 1 (1994) 229-246
7. Proudfoot A.E. Chemokine receptors: multifaceted therapeutic targets. Nat Rev Immunol 2 (2001) 106-115
8. Aukrust P., Ueland T., Muller F., Andreassen A.K., Nordoy I., Aas H., et al. Elevated circulating levels of C-C chemokines in patients with congestive heart failure. Circulation 97 (1998) 1136-1143
9. Terashima Y., Onai N., Murai M., Enomoto M., Poonpiriya V., Hamada T., et al. Pivotal function for cytoplasmic protein FROUNT in CCR2-mediated monocyte chemotaxis. Nat Immunol 6 (2005) 827-835
10. Bradenberg R.O., Chazov E., and Cherian G. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Circulation 64 (1980) 1397-1399
11. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1987) 156-159
12. Behr T.M., Wang X., Aiyar N., Coatney R.W., Li X., Koster P., et al. Monocyte chemoattractant protein-1 is upregulated in rats with volume-overload congestive heart failure. Circulation 102 (2000) 1315-1322
13. Kolattukudy P.E., Quach T., Bergese S., Breckenridge S., Hensley J., Altschuld R., et al. Myocarditis induced by targeted expression of the MCP-1 gene in murine cardiac muscle. Am J Pathol 152 (1998) 101-111
14. Hayashidani S., Tsutsui H., Shiomi T., Ikeuchi M., Matsusaka H., Suematsu N., et al. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation 108 (2003) 2134-2140
15. Jiang Y., Beller D.I., Frendl G., and Graves D.T. Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J Immunol 148 (1992) 2423-2438
16. Yamamoto T., Eckes B., Mauch C., Hartmann K., and Krieg T. Monocyte chemoattractant protein-1 enhances gene expression and synthesis of matrix metalloproteinase-1 in human fibroblasts by an autocrine IL-1 alpha loop. J Immunol 164 (2000) 6174-6179
17. Damås J.K., Eiken H.G., Øie E., Bjerkeli V., Yndestad A., Ueland T., et al. Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure. Cardiovasc Res 47 (2000) 778-787
18. Zhou L., Azfer A., Niu J., Graham S., Choudhury M., Adamski F.M., et al. Monocyte chemoattractant protein-1 induces a novel transcription factor that causes cardiac myocyte apoptosis and ventricular dysfunction. Circ Res 98 (2006) 1177-1185
19. Nienaber J.J., Tachibana H., Naga Prasad S.V., Esposito G., Wu D., Mao L., et al. Inhibition of receptor-localized PI3K preserves cardiac beta-adrenergic receptor function and ameliorates pressure overload heart failure. J Clin Invest 112 (2003) 1067-1079